{"gene":"CYP19A1","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":1985,"finding":"Human aromatase (CYP19A1/P-450AROM) was identified as a 55-kDa protein in placental microsomes. Purified protein reconstituted with NADPH-cytochrome P450 reductase and phospholipid displayed aromatase catalytic activity, establishing it as the enzymatically active subunit. Polyclonal IgG against the 55-kDa protein inhibited aromatase activity by 80% with no effect on 17α-hydroxylase or 21-hydroxylase, demonstrating enzymatic specificity.","method":"Immunoaffinity chromatography, enzyme reconstitution with purified NADPH-cytochrome P450 reductase and phospholipid, immunoblot, antibody inhibition assay","journal":"Archives of biochemistry and biophysics","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution of catalytic activity with purified components plus antibody inhibition with specificity controls; foundational biochemical characterization","pmids":["4083898"],"is_preprint":false},{"year":1988,"finding":"Expression of a chicken CYP19A1 cDNA in COS-1 cells produced high levels of aromatase activity, demonstrating that the single protein catalyzes all three successive oxidation reactions required to convert androgen (androstenedione) to estrogen. The enzyme was correctly targeted to microsomal fractions in transfected cells, with Km similar to native chicken ovarian enzyme.","method":"Heterologous cDNA expression in COS-1 cells, microsomal aromatase activity assay, subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct functional expression of cloned cDNA with enzymatic validation and correct subcellular targeting confirmed","pmids":["3182796"],"is_preprint":false},{"year":1991,"finding":"The CYP19A1 gene uses tissue-specific promoters: placenta uses upstream untranslated exons I.1 and I.2 with their associated promoters, whereas adipose tissue uses a distinct promoter approximately 110 bp upstream of exon II with a transcription start site 26 bp downstream of a TATAAA element. These alternative promoters drive tissue-specific aromatase expression.","method":"RT-PCR, primer extension analysis, S1 nuclease protection assay, Northern blotting","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (primer extension, S1 nuclease protection, Northern blot) in a single rigorous study establishing tissue-specific promoter usage","pmids":["2040633"],"is_preprint":false},{"year":1992,"finding":"A point mutation at the splice consensus sequence between exon 6 and intron 6 (GT→GC) caused aberrant splicing, inserting 87 bp of intronic sequence encoding 29 extra amino acids in-frame into aromatase mRNA. The resulting abnormal protein had trace aromatase activity when expressed in COS-7 cells, establishing that this splicing mutation is the molecular basis of aromatase deficiency in this patient.","method":"cDNA library sequencing, Northern blot, Western blot, transient expression in COS-7 cells, enzyme activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — functional expression of mutant cDNA with activity measurement, molecular characterization of splicing defect with multiple methods","pmids":["1371509"],"is_preprint":false},{"year":2015,"finding":"The acyl-carbon bond cleavage mechanism of CYP19A1 involves the iron peroxy anion intermediate (FeIII-O-O-) being trapped by the substrate's C19 aldehyde carbonyl to form a tetrahedral intermediate, which then fragments to cleave the acyl-carbon bond and release the aromatized estrogen product. This distinguishes the CYP19A1 mechanism from classical P450 monooxygenation that proceeds via Compound I.","method":"Mechanistic biochemistry review synthesizing isotopic labeling, substrate analog, and structural studies (Tier 1 compilation)","journal":"Advances in experimental medicine and biology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — mechanistic chemistry well-established by community but this paper is a review; abstract describes the mechanism without citing primary experiments performed in this paper specifically","pmids":["26002733"],"is_preprint":false},{"year":2013,"finding":"SIRT1 positively regulates CYP19A1 transcription in breast cancer cells. SIRT1 occupies the CYP19A1 promoter regions PI.3/PII and PI.4. Pharmacologic inhibition of SIRT1 or siRNA knockdown reduced aromatase mRNA and protein. SIRT1 inhibition led to increased acetylation of estrogen-related receptor alpha (ERRα), a transcription factor that activates CYP19A1 transcription in epithelial cells.","method":"Chromatin immunoprecipitation (ChIP), siRNA knockdown, small-molecule SIRT1 inhibitors, qRT-PCR, Western blot","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrates SIRT1 promoter occupancy, supported by siRNA and pharmacologic inhibition with mRNA and protein readouts; single lab, two orthogonal approaches","pmids":["23340254"],"is_preprint":false},{"year":2017,"finding":"In chicken ovary theca cells, the transcription factor SF-1 (NR5A1) directly activates CYP19A1 transcription by binding to a nuclear receptor half-site (5'-TCAAGGTCA-3') located −280 to −271 bp in the CYP19A1 promoter. Overexpression of SF-1 in DF-1 cells upregulated aromatase expression. In contrast, FOXL2 did not activate the CYP19A1 promoter in either 293T or DF-1 cells.","method":"Luciferase reporter assay, overexpression in cell lines, RT-PCR","journal":"General and comparative endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase assay with promoter binding site identified plus overexpression phenotype, single lab","pmids":["28347743"],"is_preprint":false},{"year":2017,"finding":"Mutations in the FMN-binding domain of P450 oxidoreductase (POR) at positions A115V and T142A nearly abolished CYP19A1 aromatase activity in a reconstituted in vitro system, and reduced flavin content. POR mutation P284L in the hinge region also severely reduced CYP19A1 activity. Conversely, POR mutation Q153R markedly increased CYP19A1 activity without changing flavin content, suggesting improved POR-CYP19A1 protein-protein interaction.","method":"Bacterial expression and purification of recombinant proteins, liposome reconstitution, enzyme kinetic assays, cytochrome c reduction assay, flavin content measurement","journal":"Frontiers in pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified mutant and wild-type proteins plus multiple functional assays in a single rigorous study","pmids":["28970799"],"is_preprint":false},{"year":2018,"finding":"DVL1 and DVL3 (Dishevelled proteins, key Wnt signaling mediators) localize to the nucleus and occupy at least two CYP19A1 promoters (pII and I.4) that drive overexpression in breast tumors, as well as the distal placental promoter I.1. Loss of DVL-1 or DVL-3 function led to differential changes in aromatase transcripts and in estradiol production in breast cancer cell lines.","method":"Chromatin immunoprecipitation (ChIP), loss-of-function experiments, qRT-PCR, estradiol measurement","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP showing DVL promoter occupancy plus loss-of-function with transcriptional and hormonal readouts; single lab","pmids":["30479694"],"is_preprint":false},{"year":2019,"finding":"Human placental aromatase CYP19A1 is phosphorylated at multiple sites. Phosphorylation of Y361 at the reductase-coupling interface significantly elevates aromatase catalytic activity. Additional phosphorylation sites include the active-site residue S478 and several membrane-interface residues. Two histidine residues were also found to be phosphorylated. Oxidation of two proline residues near the active site was detected and may regulate activity.","method":"Mass spectrometry (phosphoproteomics), biochemical assay, structural data analysis, cellular experiments","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mass spectrometric identification of phosphosites combined with biochemical activity assay and structural data, multiple orthogonal methods in one study","pmids":["31652308"],"is_preprint":false},{"year":2019,"finding":"CYP19A1 protein was detected on the plasma membrane of MCF-7 breast cancer cells and of normal MCF-10A breast cells by immunological methods, indicating plasma membrane localization in addition to its canonical endoplasmic reticulum localization. Anti-CYP19A1 autoantibodies were detectable in both breast cancer patients and controls, with no significant group differences.","method":"Flow cytometry / immunological detection of cell-surface CYP19A1, indirect ELISA for autoantibodies","journal":"International immunopharmacology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single immunological detection method for plasma membrane localization, single lab, no functional consequence linked to the localization","pmids":["31082724"],"is_preprint":false},{"year":2014,"finding":"FSH and TGFβ1 upregulate Cyp19a1 expression in ovarian granulosa cells via calcineurin-mediated dephosphorylation-activation of CRTC2, which binds to the Cyp19a1 PII promoter. LRH1 (NR5A2) and SF1 (NR5A1) protein levels were increased by FSH+TGFβ1, and their binding to the Cyp19a1 PII promoter was demonstrated. Calcineurin auto-inhibitory peptide abolished FSH+TGFβ1-upregulated (but not FSH-alone) aromatase activity, establishing calcineurin as pathway-specific regulator.","method":"Chromatin immunoprecipitation (ChIP), calcineurin inhibitory peptide, Western blot, aromatase activity assay, qRT-PCR","journal":"Journal of molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for transcription factor binding plus pathway epistasis via calcineurin inhibition with activity readout; single lab, multiple orthogonal methods","pmids":["25057110"],"is_preprint":false},{"year":2021,"finding":"NR1D1 (REV-ERBα), a circadian clock transcriptional repressor, binds to the RORE element on the CYP19A1 promoter in porcine granulosa cells, thereby inhibiting CYP19A1 transcription and reducing estradiol production. NR1D1 activation enhanced this repression, while NR1D1 knockdown relieved it.","method":"Chromatin immunoprecipitation (ChIP), luciferase reporter assay, NR1D1 activation/interference experiments, ELISA for estradiol","journal":"Theriogenology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct NR1D1-promoter binding with luciferase reporter and hormonal readouts; single lab","pmids":["34933195"],"is_preprint":false},{"year":2017,"finding":"LPS activates TLR4 signaling in buffalo granulosa cells, leading to increased CEBPB expression and nuclear translocation. CEBPB binds to the CYP19A1 proximal promoter (PII) and represses CYP19A1 transcription, resulting in decreased estradiol production. TLR4 inhibitor (OxPAPC) attenuated these effects.","method":"Chromatin immunoprecipitation (ChIP), TLR4 inhibitor treatment, Western blot, qRT-PCR, ELISA","journal":"Toxicology in vitro","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrates CEBPB binding at CYP19A1 PII promoter with pathway inhibitor epistasis; single lab","pmids":["28412504"],"is_preprint":false},{"year":2015,"finding":"The RNA-binding protein CELF1 directly binds Cyp19a1 mRNA and represses its translation. In Celf1 knockout mice, Cyp19a1 is posttranscriptionally upregulated, leading to excessive aromatase activity, reduced testosterone, and impaired spermiogenesis. Administration of testosterone or the aromatase inhibitor letrozole partially rescued the spermiogenesis defects, placing CELF1-mediated translational repression of CYP19A1 in the pathway controlling intratesticular testosterone levels required for spermiogenesis.","method":"In vivo/in vitro RNA binding assay, reporter assay for translational repression, Celf1 knockout mouse model, hormone measurements, rescue experiments with testosterone and letrozole","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct RNA binding demonstrated, translational repression confirmed in reporter assay, in vivo knockout with defined phenotype, pharmacological rescue; multiple orthogonal methods","pmids":["26169831"],"is_preprint":false},{"year":2018,"finding":"METTL3, an m6A methyltransferase, enhances CYP19A1 mRNA translation efficiency in an m6A-dependent manner in NSCLC cells. METTL3 interacts with translation initiation factors and binds to CYP19A1 mRNA, promoting aromatase protein synthesis and estrogen production to drive NSCLC metastasis. Pharmacological inhibition of METTL3 or eIF4E abolished CYP19A1 protein synthesis.","method":"Translatomics, m6A-seq, RNA immunoprecipitation, co-immunoprecipitation, Western blot, METTL3 knockdown/knockout, eIF4E inhibitor, in vitro and in vivo invasion assays","journal":"Cell & bioscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (translatomics, RIP, Co-IP, pharmacological inhibition) demonstrating METTL3-eIF4E-CYP19A1 translation axis; single lab","pmids":["38238831"],"is_preprint":false},{"year":2018,"finding":"CTBP1 and EP300 bind to the CYP19A1 promoter in PCa cells and downregulate CYP19A1 expression. Estradiol, acting through estrogen receptor beta, releases CTBP1 from the CYP19A1 promoter, thereby de-repressing CYP19A1 transcription and increasing estradiol production. In CTBP1-depleted PCa xenografts in NSG mice, CYP19A1 expression and intratumoral estradiol were increased.","method":"Chromatin immunoprecipitation (ChIP), CTBP1 depletion, xenograft mouse model, hormone measurement, Western blot","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating CTBP1/EP300 promoter occupancy with in vivo depletion validation; single lab, multiple methods","pmids":["30152543"],"is_preprint":false},{"year":2017,"finding":"RORα directly occupies the promoter of CYP19A1 in THP-1 monocytes and HUVEC cells, as shown by ChIP. Modulating RORα activity with specific ligands (CPG 52608 and SR1001) altered CYP19A1 expression, establishing CYP19A1 as a direct RORα target gene. Simvastatin downregulated CYP19A1 expression, and this was partially prevented by RORα ligands.","method":"Chromatin immunoprecipitation (ChIP), RORα ligand treatment, qRT-PCR","journal":"Cell biology international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirms RORα occupancy at CYP19A1 promoter, supported by pharmacological modulation of RORα activity; single lab","pmids":["27925372"],"is_preprint":false},{"year":2020,"finding":"In chicken embryos, lentiviral-mediated knockdown of CYP19A1 caused male sex reversal, while overexpression drove female sex differentiation, establishing CYP19A1 as both necessary and sufficient to initiate female gonadal sex differentiation. CYP19A1 showed sexually dimorphic expression in female gonads from embryonic day 5.5, localized to ovarian medullas.","method":"Lentiviral in ovo knockdown and overexpression, aromatase inhibitor treatment, immunohistochemistry, gonadal sex phenotype analysis","journal":"Bioscience reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — loss- and gain-of-function in vivo experiments with defined gonadal phenotype, combined with pharmacological inhibition; multiple orthogonal approaches","pmids":["32990306"],"is_preprint":false},{"year":2021,"finding":"Transcription factors ESR1, ESR2, and NR5A2 form a functional regulatory network controlling CYP19A1 expression in chicken theca cells. ESR1 and NR5A2 activated the CYP19A1 promoter in luciferase assays; overexpression of ESR1, ESR2, or NR5A2 upregulated CYP19A1 protein and these factors mutually restricted each other. In contrast, FOXL2 did not regulate CYP19A1 expression at embryonic stages or after sexual maturity in chicken.","method":"Luciferase reporter assay, overexpression in DF-1 and theca cells, Western blot, immunofluorescence","journal":"General and comparative endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase assay plus overexpression in physiologically relevant theca cell culture; single lab, two orthogonal methods","pmids":["34710471"],"is_preprint":false},{"year":2023,"finding":"CYP19A1 expression is increased in the lungs of SARS-CoV-2-infected male golden hamsters and in human autopsy lungs of males. A CYP19A1-activity-increasing mutation was associated with severe COVID-19 in men. Increased pulmonary CYP19A1 was associated with dysregulated plasma sex hormones and impaired long-term lung function specifically in males. Treatment with the CYP19A1 inhibitor letrozole improved lung function and restored sex hormone balance in infected male hamsters.","method":"Exome sequencing with machine-learning analysis, human autopsy immunohistochemistry, hamster infection model with letrozole treatment, lung function measurement, hormone assays","journal":"Cell reports. Medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo pharmacological inhibition with functional readout in animal model plus human genetic and autopsy data; multi-method, single study","pmids":["37572667"],"is_preprint":false},{"year":2020,"finding":"miR-326 inhibits CYP19A1 transcription in buffalo granulosa cells by upregulating CREB, which activates C/EBP-β; increased C/EBP-β then binds the CYP19A1 PII promoter (shown by ChIP) and reduces RNA polymerase II binding, thereby decreasing CYP19A1 mRNA and estradiol-17β production.","method":"miRNA mimic transfection, ChIP for C/EBP-β and RNA Pol II at CYP19A1 PII promoter, qRT-PCR, ELISA","journal":"The Journal of steroid biochemistry and molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating transcription factor binding changes at CYP19A1 promoter with miRNA functional experiments; single lab","pmids":["31996328"],"is_preprint":false},{"year":2015,"finding":"LPS-mediated inhibition of CYP19A1 expression and estradiol production in granulosa cells involves HDAC-dependent histone deacetylation at H3K9 of the CYP19A1 PII proximal promoter and NF-κB nuclear translocation. The HDAC inhibitor TSA prevented H3 deacetylation at PII (confirmed by ChIP) and restored CYP19A1 expression and estradiol production, placing HDAC activity as a downstream effector of LPS/NF-κB signaling in CYP19A1 repression.","method":"HDAC inhibitor (TSA), ChIP for H3(K9/14) acetylation at CYP19A1 PII, NF-κB nuclear translocation assay, qRT-PCR, ELISA","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating histone modification at CYP19A1 promoter with pharmacological reversal; single lab, multiple methods","pmids":["26213324"],"is_preprint":false},{"year":2017,"finding":"LRH-1 (liver receptor homolog-1) protein directly binds the CYP19A1 promoter and increases its transcriptional activity in porcine granulosa cells (shown by luciferase and ChIP assays). miR-1275 targets the 3'UTR of LRH-1 mRNA (not CYP19A1 directly), suppressing LRH-1 expression and thereby reducing CYP19A1 transcription, estradiol synthesis, and promoting granulosa cell apoptosis.","method":"Luciferase reporter assay, ChIP, miRNA overexpression/knockdown, in vitro LRH-1 overexpression/knockdown, flow cytometry","journal":"Biochimica et biophysica acta. Gene regulatory mechanisms","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and luciferase assay confirm LRH-1 binding to CYP19A1 promoter; miRNA-target validated by luciferase; single lab","pmids":["29378329"],"is_preprint":false}],"current_model":"CYP19A1 encodes aromatase, a cytochrome P450 enzyme resident in the endoplasmic reticulum (and detectable on the plasma membrane) that catalyzes three successive oxidations of androgen substrates via an iron peroxy-anion-mediated acyl-carbon cleavage mechanism to produce estrogens; its activity is regulated post-translationally by POR-dependent electron transfer (modulated by POR mutations) and by phosphorylation at multiple sites including Y361 (activating) and S478, and transcriptionally through a network of tissue-specific promoters controlled by SF-1/NR5A1, LRH-1/NR5A2, ESR1, ESR2, RORα, NR1D1, CTBP1/EP300, SIRT1, DVL proteins, and epigenetic marks (histone acetylation via HDACs, CRTC2/calcineurin), while at the post-transcriptional level CELF1 represses Cyp19a1 mRNA translation and METTL3/eIF4E promotes it via m6A modification."},"narrative":{"mechanistic_narrative":"CYP19A1 encodes aromatase, a microsomal cytochrome P450 that is the single enzyme catalyzing the three successive oxidations converting androgens to estrogens, the committed step of estrogen biosynthesis [PMID:4083898, PMID:3182796]. Purified placental aromatase reconstituted with NADPH-cytochrome P450 reductase and phospholipid is catalytically active and immunologically distinct from other steroid hydroxylases [PMID:4083898], and heterologous expression of a single cDNA confers full androstenedione-to-estrogen conversion with correct microsomal targeting [PMID:3182796]. Catalysis proceeds through an unusual iron peroxy-anion intermediate that is trapped by the substrate C19 aldehyde to cleave the acyl-carbon bond and aromatize the steroid A-ring, distinguishing it from canonical Compound I P450 chemistry [PMID:26002733]. Enzyme activity depends on productive electron transfer from POR, as POR FMN-domain and hinge mutations abolish or enhance aromatase activity in reconstituted systems [PMID:28970799], and is further tuned post-translationally by phosphorylation, including activating phosphorylation of Y361 at the reductase-coupling interface [PMID:31652308]. Transcription is governed by a network of tissue-specific promoters [PMID:2040633] integrating nuclear-receptor activators (SF-1/NR5A1, LRH-1/NR5A2, ESR1/ESR2, RORα) and repressors (NR1D1, CEBPB, CTBP1/EP300), along with epigenetic and signaling inputs such as SIRT1, CRTC2/calcineurin, HDAC-dependent H3K9 acetylation, and DVL proteins [PMID:23340254, PMID:28347743, PMID:25057110, PMID:34933195, PMID:30152543, PMID:27925372, PMID:34710471, PMID:26213324, PMID:30479694]; at the post-transcriptional level CELF1 represses Cyp19a1 mRNA translation while METTL3/eIF4E promotes it via m6A [PMID:26169831, PMID:38238831]. Functionally, aromatase-derived estrogen drives gonadal sex differentiation, being necessary and sufficient for female development in the avian gonad [PMID:32990306], controls intratesticular testosterone required for spermiogenesis [PMID:26169831], and contributes to pathological estrogen production in cancers and to sex-biased COVID-19 lung pathology [PMID:30152543, PMID:37572667]. Loss-of-function splicing mutations that cripple aromatase activity underlie human aromatase deficiency [PMID:1371509].","teleology":[{"year":1985,"claim":"Established that aromatase is a discrete P450 protein and the catalytically active subunit, answering whether estrogen synthesis required a dedicated enzyme.","evidence":"Immunoaffinity purification of 55-kDa placental protein, reconstitution with NADPH-P450 reductase and phospholipid, antibody inhibition with specificity controls","pmids":["4083898"],"confidence":"High","gaps":["Did not resolve whether one protein performs all three oxidations","No structural or mechanistic detail of catalysis"]},{"year":1988,"claim":"Demonstrated that a single CYP19A1 gene product catalyzes all three oxidation steps from androgen to estrogen, settling the one-enzyme question.","evidence":"Heterologous expression of chicken CYP19A1 cDNA in COS-1 cells with microsomal activity assay and subcellular fractionation","pmids":["3182796"],"confidence":"High","gaps":["Chemical mechanism of acyl-carbon cleavage not defined","Regulation in vivo not addressed"]},{"year":1991,"claim":"Revealed that tissue-specific aromatase expression is driven by alternative promoters, explaining how the same enzyme is differentially produced across tissues.","evidence":"RT-PCR, primer extension, S1 nuclease protection and Northern blot of placental vs adipose transcripts","pmids":["2040633"],"confidence":"High","gaps":["Trans-acting factors driving each promoter not identified here","Did not address regulation in disease"]},{"year":1992,"claim":"Linked a CYP19A1 splice mutation directly to human aromatase deficiency, establishing the gene as the disease locus.","evidence":"Patient cDNA sequencing, Northern/Western blot, expression of mutant cDNA in COS-7 with activity assay","pmids":["1371509"],"confidence":"High","gaps":["Single patient mutation","Genotype-phenotype spectrum not defined"]},{"year":2015,"claim":"Defined the unusual acyl-carbon cleavage chemistry of aromatization, distinguishing CYP19A1 from canonical monooxygenase P450s.","evidence":"Mechanistic biochemistry review synthesizing isotopic, substrate-analog and structural studies","pmids":["26002733"],"confidence":"Medium","gaps":["Review rather than new primary experiment","Intermediate species not directly observed in this work"]},{"year":2015,"claim":"Identified CELF1-mediated translational repression of Cyp19a1 as a post-transcriptional control point governing intratesticular testosterone and spermiogenesis.","evidence":"RNA-binding and reporter assays, Celf1 knockout mice, hormone measurement, testosterone/letrozole rescue","pmids":["26169831"],"confidence":"High","gaps":["CELF1 binding element on Cyp19a1 mRNA not mapped","Translational machinery involved not detailed"]},{"year":2017,"claim":"Showed POR electron-transfer function controls aromatase output, with FMN-domain and hinge mutations bidirectionally modulating activity.","evidence":"Bacterial expression, liposome reconstitution of WT/mutant POR with CYP19A1, kinetics, cytochrome c reduction, flavin content","pmids":["28970799"],"confidence":"High","gaps":["Structural basis of altered POR-CYP19A1 interaction not solved","Tissue-level consequences not tested"]},{"year":2017,"claim":"Mapped multiple nuclear-receptor and signaling regulators (SF-1, RORα, LRH-1, LPS/CEBPB) to specific CYP19A1 promoter elements, building the transcriptional network.","evidence":"ChIP, luciferase reporters, overexpression/knockdown and ligand/pathway-inhibitor experiments in granulosa, theca, monocyte and endothelial systems","pmids":["28347743","27925372","29378329","28412504"],"confidence":"Medium","gaps":["Largely single-lab, non-human cell systems","Combinatorial promoter logic across factors not integrated"]},{"year":2019,"claim":"Established phosphorylation, including activating Y361 at the reductase interface, as a post-translational regulator of aromatase activity.","evidence":"Phosphoproteomic mass spectrometry of placental aromatase with biochemical activity assay and structural analysis","pmids":["31652308"],"confidence":"High","gaps":["Kinases responsible not identified","Physiological stimuli driving phosphorylation unknown"]},{"year":2019,"claim":"Reported plasma-membrane localization of CYP19A1 in addition to the ER, raising the possibility of non-canonical surface display.","evidence":"Flow cytometry/immunological detection on MCF-7 and MCF-10A cells, autoantibody ELISA","pmids":["31082724"],"confidence":"Low","gaps":["Single immunological method without orthogonal confirmation","No functional consequence assigned to surface localization"]},{"year":2020,"claim":"Demonstrated that CYP19A1 is necessary and sufficient to initiate female gonadal sex differentiation in vivo.","evidence":"Lentiviral knockdown and overexpression in chicken embryos, aromatase inhibitor, immunohistochemistry, gonadal phenotyping","pmids":["32990306"],"confidence":"High","gaps":["Mammalian relevance not addressed","Upstream initiating cue for dimorphic expression unresolved"]},{"year":2023,"claim":"Expanded CYP19A1's pathophysiology beyond reproduction, linking elevated pulmonary aromatase to sex-biased COVID-19 severity.","evidence":"Hamster infection model with letrozole treatment, human autopsy IHC, exome sequencing with machine learning, hormone and lung-function assays","pmids":["37572667"],"confidence":"Medium","gaps":["Mechanism of pulmonary CYP19A1 induction unclear","Causality of the activating mutation not functionally proven"]},{"year":null,"claim":"How the diverse transcriptional, translational (m6A), and post-translational inputs are integrated into a coherent, tissue- and context-specific control of aromatase output remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking promoter choice, phosphorylation, and POR coupling","Human structural mechanism of acyl-carbon cleavage not directly visualized in the corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,1,4,7]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,4]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,1]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,4]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,6,16,17,19]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[18,14]}],"complexes":[],"partners":["POR","NR5A1","NR5A2","ESR1","ESR2","RORA","CELF1","METTL3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P11511","full_name":"Aromatase","aliases":["CYPXIX","Cytochrome P-450AROM","Cytochrome P450 19A1","Estrogen synthase"],"length_aa":503,"mass_kda":57.9,"function":"A cytochrome P450 monooxygenase that catalyzes the conversion of C19 androgens, androst-4-ene-3,17-dione (androstenedione) and testosterone to the C18 estrogens, estrone and estradiol, respectively (PubMed:27702664, PubMed:2848247). Catalyzes three successive oxidations of C19 androgens: two conventional oxidations at C19 yielding 19-hydroxy and 19-oxo/19-aldehyde derivatives, followed by a third oxidative aromatization step that involves C1-beta hydrogen abstraction combined with cleavage of the C10-C19 bond to yield a phenolic A ring and formic acid (PubMed:20385561). Alternatively, the third oxidative reaction yields a 19-norsteroid and formic acid. Converts dihydrotestosterone to delta1,10-dehydro 19-nordihydrotestosterone and may play a role in homeostasis of this potent androgen (PubMed:22773874). Also displays 2-hydroxylase activity toward estrone (PubMed:22773874). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) (PubMed:20385561, PubMed:22773874)","subcellular_location":"Endoplasmic reticulum membrane; Microsome membrane","url":"https://www.uniprot.org/uniprotkb/P11511/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CYP19A1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CYP19A1","total_profiled":1310},"omim":[{"mim_id":"616429","title":"SUSHI DOMAIN-CONTAINING PROTEIN 3; SUSD3","url":"https://www.omim.org/entry/616429"},{"mim_id":"613546","title":"AROMATASE DEFICIENCY","url":"https://www.omim.org/entry/613546"},{"mim_id":"607856","title":"CINGULIN-LIKE 1; CGNL1","url":"https://www.omim.org/entry/607856"},{"mim_id":"605692","title":"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 7; TRPM7","url":"https://www.omim.org/entry/605692"},{"mim_id":"605112","title":"TROPOMODULIN 3; TMOD3","url":"https://www.omim.org/entry/605112"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Mitochondria","reliability":"Uncertain"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"placenta","ntpm":117.1}],"url":"https://www.proteinatlas.org/search/CYP19A1"},"hgnc":{"alias_symbol":["ARO","P-450AROM","CPV1","ARO1","CYAR","aromatase"],"prev_symbol":["CYP19"]},"alphafold":{"accession":"P11511","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P11511","model_url":"https://alphafold.ebi.ac.uk/files/AF-P11511-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P11511-F1-predicted_aligned_error_v6.png","plddt_mean":91.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CYP19A1","jax_strain_url":"https://www.jax.org/strain/search?query=CYP19A1"},"sequence":{"accession":"P11511","fasta_url":"https://rest.uniprot.org/uniprotkb/P11511.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P11511/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P11511"}},"corpus_meta":[{"pmid":"4083898","id":"PMC_4083898","title":"Preparation and characterization of polyclonal and monoclonal antibodies against human aromatase cytochrome P-450 (P-450AROM), and their use in its purification.","date":"1985","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/4083898","citation_count":166,"is_preprint":false},{"pmid":"1759503","id":"PMC_1759503","title":"Construction of genetically defined double aro mutants of Salmonella typhi.","date":"1991","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/1759503","citation_count":156,"is_preprint":false},{"pmid":"2040633","id":"PMC_2040633","title":"Tissue-specific expression of human P-450AROM. The promoter responsible for expression in adipose tissue is different from that utilized in placenta.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2040633","citation_count":152,"is_preprint":false},{"pmid":"18978044","id":"PMC_18978044","title":"The Crp-activated small noncoding regulatory RNA CyaR (RyeE) links nutritional status to group behavior.","date":"2008","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/18978044","citation_count":143,"is_preprint":false},{"pmid":"38583092","id":"PMC_38583092","title":"Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial.","date":"2024","source":"JAMA cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/38583092","citation_count":138,"is_preprint":false},{"pmid":"3182796","id":"PMC_3182796","title":"The expression of a functional cDNA encoding the chicken cytochrome P-450arom (aromatase) that catalyzes the formation of estrogen from androgen.","date":"1988","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3182796","citation_count":131,"is_preprint":false},{"pmid":"18399940","id":"PMC_18399940","title":"Systematic deletion of Salmonella small RNA genes identifies CyaR, a conserved CRP-dependent riboregulator of OmpX synthesis.","date":"2008","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/18399940","citation_count":128,"is_preprint":false},{"pmid":"18619465","id":"PMC_18619465","title":"Down-regulation of outer membrane proteins by noncoding RNAs: unraveling the cAMP-CRP- and sigmaE-dependent CyaR-ompX regulatory case.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18619465","citation_count":96,"is_preprint":false},{"pmid":"35205347","id":"PMC_35205347","title":"A Review on CYP11A1, CYP17A1, and CYP19A1 Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (PCOS) and Infertility.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35205347","citation_count":85,"is_preprint":false},{"pmid":"15385459","id":"PMC_15385459","title":"Growth, virulence, and immunogenicity of Listeria monocytogenes aro mutants.","date":"2004","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15385459","citation_count":77,"is_preprint":false},{"pmid":"1371509","id":"PMC_1371509","title":"Biochemical and molecular genetic analyses on placental aromatase (P-450AROM) deficiency.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1371509","citation_count":75,"is_preprint":false},{"pmid":"19438456","id":"PMC_19438456","title":"Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss.","date":"2009","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/19438456","citation_count":68,"is_preprint":false},{"pmid":"36513186","id":"PMC_36513186","title":"A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis.","date":"2022","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/36513186","citation_count":67,"is_preprint":false},{"pmid":"19276634","id":"PMC_19276634","title":"Dimorphic expression of dmrt1 and cyp19a1 (ovarian aromatase) during early gonadal development in pejerrey, Odontesthes bonariensis.","date":"2009","source":"Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/19276634","citation_count":62,"is_preprint":false},{"pmid":"23340254","id":"PMC_23340254","title":"SIRT1 positively regulates breast cancer associated human aromatase (CYP19A1) expression.","date":"2013","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23340254","citation_count":62,"is_preprint":false},{"pmid":"26574572","id":"PMC_26574572","title":"CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer.","date":"2015","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26574572","citation_count":56,"is_preprint":false},{"pmid":"29378329","id":"PMC_29378329","title":"miR-1275 controls granulosa cell apoptosis and estradiol synthesis by impairing LRH-1/CYP19A1 axis.","date":"2018","source":"Biochimica et biophysica acta. Gene regulatory mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/29378329","citation_count":47,"is_preprint":false},{"pmid":"27167072","id":"PMC_27167072","title":"Epigenetic alterations of CYP19A1 gene in Cumulus cells and its relevance to infertility in endometriosis.","date":"2016","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27167072","citation_count":46,"is_preprint":false},{"pmid":"24157654","id":"PMC_24157654","title":"Promoter methylation of CYP19A1 gene in Chinese polycystic ovary syndrome patients.","date":"2013","source":"Gynecologic and obstetric investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24157654","citation_count":45,"is_preprint":false},{"pmid":"21296134","id":"PMC_21296134","title":"Aflatoxin B1--a potential endocrine disruptor--up-regulates CYP19A1 in JEG-3 cells.","date":"2011","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/21296134","citation_count":43,"is_preprint":false},{"pmid":"17119036","id":"PMC_17119036","title":"Genetic polymorphisms of the CYP19A1 gene and breast cancer survival.","date":"2006","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17119036","citation_count":42,"is_preprint":false},{"pmid":"28347743","id":"PMC_28347743","title":"Transcription of CYP19A1 is directly regulated by SF-1 in the theca cells of ovary follicles in chicken.","date":"2017","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28347743","citation_count":42,"is_preprint":false},{"pmid":"30479694","id":"PMC_30479694","title":"DVL1 and DVL3 differentially localize to CYP19A1 promoters and regulate aromatase mRNA in breast cancer cells.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/30479694","citation_count":41,"is_preprint":false},{"pmid":"23883521","id":"PMC_23883521","title":"Expression and sequence evolution of aromatase cyp19a1 and other sexual development genes in East African cichlid fishes.","date":"2013","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/23883521","citation_count":41,"is_preprint":false},{"pmid":"30226860","id":"PMC_30226860","title":"Sex-specific dmrt1 and cyp19a1 methylation and alternative splicing in gonads of the protandrous hermaphrodite barramundi.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30226860","citation_count":40,"is_preprint":false},{"pmid":"29934332","id":"PMC_29934332","title":"An Engineered Aro1 Protein Degradation Approach for Increased cis,cis-Muconic Acid Biosynthesis in Saccharomyces cerevisiae.","date":"2018","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/29934332","citation_count":37,"is_preprint":false},{"pmid":"18310348","id":"PMC_18310348","title":"aro mutations in Salmonella enterica cause defects in cell wall and outer membrane integrity.","date":"2008","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/18310348","citation_count":37,"is_preprint":false},{"pmid":"17582409","id":"PMC_17582409","title":"Local expression of CYP19A1 and CYP19A2 in developing and adult killifish (Fundulus heteroclitus).","date":"2007","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17582409","citation_count":35,"is_preprint":false},{"pmid":"30414951","id":"PMC_30414951","title":"Malignant transformation of canine oral papillomavirus (CPV1)-associated papillomas in dogs: An emerging concern?","date":"2018","source":"Papillomavirus research (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/30414951","citation_count":33,"is_preprint":false},{"pmid":"19794152","id":"PMC_19794152","title":"DNA methylation is not involved in preovulatory down-regulation of CYP11A1, HSD3B1, and CYP19A1 in bovine follicles but may have a role in permanent silencing of CYP19A1 in large granulosa lutein cells.","date":"2009","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/19794152","citation_count":33,"is_preprint":false},{"pmid":"2848727","id":"PMC_2848727","title":"The Saccharomyces cerevisiae ARO1 gene. An example of the co-ordinate regulation of five enzymes on a single biosynthetic pathway.","date":"1988","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/2848727","citation_count":32,"is_preprint":false},{"pmid":"17507620","id":"PMC_17507620","title":"Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women.","date":"2007","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17507620","citation_count":32,"is_preprint":false},{"pmid":"26213324","id":"PMC_26213324","title":"HDAC inhibitor prevents LPS mediated inhibition of CYP19A1 expression and 17β-estradiol production in granulosa cells.","date":"2015","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26213324","citation_count":29,"is_preprint":false},{"pmid":"32247112","id":"PMC_32247112","title":"2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study.","date":"2020","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32247112","citation_count":28,"is_preprint":false},{"pmid":"33152430","id":"PMC_33152430","title":"Upregulation of Cyp19a1 and PPAR-γ in ovarian steroidogenic pathway by Ficus religiosa: A potential cure for polycystic ovary syndrome.","date":"2020","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33152430","citation_count":28,"is_preprint":false},{"pmid":"17893373","id":"PMC_17893373","title":"Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants.","date":"2007","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/17893373","citation_count":28,"is_preprint":false},{"pmid":"22638611","id":"PMC_22638611","title":"Estrogen synthesis genes CYP19A1, HSD3B1, and HSD3B2 in hypertensive disorders of pregnancy.","date":"2012","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/22638611","citation_count":28,"is_preprint":false},{"pmid":"33852023","id":"PMC_33852023","title":"Effect of quorum-sensing molecule 2-phenylethanol and ARO genes on Saccharomyces cerevisiae biofilm.","date":"2021","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/33852023","citation_count":28,"is_preprint":false},{"pmid":"19500729","id":"PMC_19500729","title":"Alternative 5'-untranslated first exons of the mouse Cyp19A1 (aromatase) gene.","date":"2009","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19500729","citation_count":28,"is_preprint":false},{"pmid":"25124466","id":"PMC_25124466","title":"Association study of ERβ, AR, and CYP19A1 genes and MtF transsexualism.","date":"2014","source":"The journal of sexual medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25124466","citation_count":27,"is_preprint":false},{"pmid":"32653739","id":"PMC_32653739","title":"Upregulation of miR-146b promotes porcine ovarian granulosa cell apoptosis by attenuating CYP19A1.","date":"2020","source":"Domestic animal endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/32653739","citation_count":27,"is_preprint":false},{"pmid":"25935582","id":"PMC_25935582","title":"CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.","date":"2015","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/25935582","citation_count":27,"is_preprint":false},{"pmid":"21479914","id":"PMC_21479914","title":"Variation in the CYP19A1 gene and risk of colon and rectal cancer.","date":"2011","source":"Cancer causes & control : CCC","url":"https://pubmed.ncbi.nlm.nih.gov/21479914","citation_count":26,"is_preprint":false},{"pmid":"19549443","id":"PMC_19549443","title":"Aromatase gene (CYP19A1) variants, female infertility and ovarian stimulation outcome: a preliminary report.","date":"2009","source":"Reproductive biomedicine online","url":"https://pubmed.ncbi.nlm.nih.gov/19549443","citation_count":26,"is_preprint":false},{"pmid":"25057110","id":"PMC_25057110","title":"Calcineurin and CRTC2 mediate FSH and TGFβ1 upregulation of Cyp19a1 and Nr5a in ovary granulosa cells.","date":"2014","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25057110","citation_count":26,"is_preprint":false},{"pmid":"34933195","id":"PMC_34933195","title":"NR1D1 targeting CYP19A1 inhibits estrogen synthesis in ovarian granulosa cells.","date":"2021","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/34933195","citation_count":24,"is_preprint":false},{"pmid":"31514021","id":"PMC_31514021","title":"Nitrophenols suppress steroidogenesis in prehierarchical chicken ovarian follicles by targeting STAR, HSD3B1, and CYP19A1 and downregulating LH and estrogen receptor expression.","date":"2019","source":"Domestic animal endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31514021","citation_count":24,"is_preprint":false},{"pmid":"28970799","id":"PMC_28970799","title":"Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase.","date":"2017","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28970799","citation_count":24,"is_preprint":false},{"pmid":"24803183","id":"PMC_24803183","title":"Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival.","date":"2014","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24803183","citation_count":24,"is_preprint":false},{"pmid":"27747906","id":"PMC_27747906","title":"Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients.","date":"2016","source":"British journal of clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27747906","citation_count":24,"is_preprint":false},{"pmid":"25401953","id":"PMC_25401953","title":"A retrospective investigation on canine papillomavirus 1 (CPV1) in oral oncogenesis reveals dogs are not a suitable animal model for high-risk HPV-induced oral cancer.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25401953","citation_count":23,"is_preprint":false},{"pmid":"9854590","id":"PMC_9854590","title":"Overexpression of TTF-1 and PAX-8 restores thyroglobulin gene promoter activity in ARO and WRO cell lines.","date":"1998","source":"Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/9854590","citation_count":23,"is_preprint":false},{"pmid":"31082724","id":"PMC_31082724","title":"Plasma membrane localization of CYP4Z1 and CYP19A1 and the detection of anti-CYP19A1 autoantibodies in humans.","date":"2019","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31082724","citation_count":23,"is_preprint":false},{"pmid":"34871762","id":"PMC_34871762","title":"Copper exposure disrupts ovarian steroidogenesis in human ovarian granulosa cells via the FSHR/CYP19A1 pathway and alters methylation patterns on the SF-1 gene promoter.","date":"2021","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34871762","citation_count":23,"is_preprint":false},{"pmid":"26415088","id":"PMC_26415088","title":"Sex- and Obesity-specific Association of Aromatase (CYP19A1) Gene Variant with Apolipoprotein B and Hypertension.","date":"2015","source":"Archives of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/26415088","citation_count":22,"is_preprint":false},{"pmid":"16872606","id":"PMC_16872606","title":"Tissue- and sex-specific regulation of CYP19A1 expression in the Atlantic croaker (Micropogonias undulatus).","date":"2006","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16872606","citation_count":22,"is_preprint":false},{"pmid":"25773531","id":"PMC_25773531","title":"Down-regulation of the CYP19A1 gene in cumulus cells of infertile women with endometriosis.","date":"2015","source":"Reproductive biomedicine online","url":"https://pubmed.ncbi.nlm.nih.gov/25773531","citation_count":22,"is_preprint":false},{"pmid":"6355828","id":"PMC_6355828","title":"Isolation of the ARO1 cluster gene of Saccharomyces cerevisiae.","date":"1983","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/6355828","citation_count":21,"is_preprint":false},{"pmid":"31652308","id":"PMC_31652308","title":"Phosphorylation of human placental aromatase CYP19A1.","date":"2019","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/31652308","citation_count":21,"is_preprint":false},{"pmid":"34365057","id":"PMC_34365057","title":"New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.","date":"2021","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34365057","citation_count":21,"is_preprint":false},{"pmid":"31371045","id":"PMC_31371045","title":"Sequence variants in FSHR and CYP19A1 genes and the ovarian response to controlled ovarian stimulation.","date":"2019","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/31371045","citation_count":21,"is_preprint":false},{"pmid":"18199708","id":"PMC_18199708","title":"Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study.","date":"2008","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18199708","citation_count":21,"is_preprint":false},{"pmid":"30284180","id":"PMC_30284180","title":"The Importance of CYP19A1 in Estrogen Receptor-Positive Cholangiocarcinoma.","date":"2018","source":"Hormones & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30284180","citation_count":20,"is_preprint":false},{"pmid":"31069202","id":"PMC_31069202","title":"Placental ESRRG-CYP19A1 Expressions and Circulating 17-Beta Estradiol in IUGR Pregnancies.","date":"2019","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/31069202","citation_count":20,"is_preprint":false},{"pmid":"35545835","id":"PMC_35545835","title":"Ursolic acid silences CYP19A1/aromatase to suppress gastric cancer growth.","date":"2022","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35545835","citation_count":20,"is_preprint":false},{"pmid":"26002733","id":"PMC_26002733","title":"Acyl-Carbon Bond Cleaving Cytochrome P450 Enzymes: CYP17A1, CYP19A1 and CYP51A1.","date":"2015","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/26002733","citation_count":20,"is_preprint":false},{"pmid":"32990306","id":"PMC_32990306","title":"CYP19A1 (aromatase) dominates female gonadal differentiation in chicken (Gallus gallus) embryos sexual differentiation.","date":"2020","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/32990306","citation_count":19,"is_preprint":false},{"pmid":"30152543","id":"PMC_30152543","title":"CTBP1/CYP19A1/estradiol axis together with adipose tissue impacts over prostate cancer growth associated to metabolic syndrome.","date":"2018","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30152543","citation_count":19,"is_preprint":false},{"pmid":"37572667","id":"PMC_37572667","title":"CYP19A1 mediates severe SARS-CoV-2 disease outcome in males.","date":"2023","source":"Cell reports. Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37572667","citation_count":18,"is_preprint":false},{"pmid":"35657638","id":"PMC_35657638","title":"LINC00094/miR-19a-3p/CYP19A1 axis affects the sensitivity of ER positive breast cancer cells to Letrozole through EMT pathway.","date":"2022","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/35657638","citation_count":18,"is_preprint":false},{"pmid":"29807722","id":"PMC_29807722","title":"Candida albicans Aro1 affects cell wall integrity, biofilm formation and virulence.","date":"2018","source":"Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/29807722","citation_count":17,"is_preprint":false},{"pmid":"22706627","id":"PMC_22706627","title":"AKT-aro and HER2-aro, models for de novo resistance to aromatase inhibitors; molecular characterization and inhibitor response studies.","date":"2012","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/22706627","citation_count":17,"is_preprint":false},{"pmid":"27925372","id":"PMC_27925372","title":"CYP19A1, MIF and ABCA1 genes are targets of the RORα in monocyte and endothelial cells.","date":"2017","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/27925372","citation_count":17,"is_preprint":false},{"pmid":"32318648","id":"PMC_32318648","title":"Novel CYP19A1 Mutations Extend the Genotype-Phenotype Correlation and Reveal the Impact on Ovarian Function.","date":"2020","source":"Journal of the Endocrine Society","url":"https://pubmed.ncbi.nlm.nih.gov/32318648","citation_count":17,"is_preprint":false},{"pmid":"31730745","id":"PMC_31730745","title":"Aromatase (CYP19A1) gene variants, sex steroid levels, and late-life depression.","date":"2019","source":"Depression and anxiety","url":"https://pubmed.ncbi.nlm.nih.gov/31730745","citation_count":16,"is_preprint":false},{"pmid":"28814372","id":"PMC_28814372","title":"Association of CYP19A1 gene polymorphisms with anoestrus in water buffaloes.","date":"2018","source":"Reproduction, fertility, and development","url":"https://pubmed.ncbi.nlm.nih.gov/28814372","citation_count":16,"is_preprint":false},{"pmid":"24612124","id":"PMC_24612124","title":"Cyp19a1 (aromatase) expression in the Xenopus brain at different developmental stages.","date":"2014","source":"Journal of neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24612124","citation_count":16,"is_preprint":false},{"pmid":"34710471","id":"PMC_34710471","title":"Transcriptional regulation of CYP19A1 expression in chickens: ESR1, ESR2 and NR5A2 form a functional network.","date":"2021","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/34710471","citation_count":15,"is_preprint":false},{"pmid":"26169831","id":"PMC_26169831","title":"Hypogonadism Associated with Cyp19a1 (Aromatase) Posttranscriptional Upregulation in Celf1 Knockout Mice.","date":"2015","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26169831","citation_count":15,"is_preprint":false},{"pmid":"23116507","id":"PMC_23116507","title":"Association between CYP19A1 genotype and pubertal sagittal jaw growth.","date":"2012","source":"American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics","url":"https://pubmed.ncbi.nlm.nih.gov/23116507","citation_count":15,"is_preprint":false},{"pmid":"28412504","id":"PMC_28412504","title":"Endotoxin induced TLR4 signaling downregulates CYP19A1 expression through CEBPB in buffalo granulosa cells.","date":"2017","source":"Toxicology in vitro : an international journal published in association with BIBRA","url":"https://pubmed.ncbi.nlm.nih.gov/28412504","citation_count":15,"is_preprint":false},{"pmid":"35615684","id":"PMC_35615684","title":"The Association of CYP17A1, CYP19A1, and SHBG Gene Polymorphisms in Polycystic Ovary Syndrome Susceptibility: A Systematic Review and Meta-Analysis.","date":"2022","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35615684","citation_count":14,"is_preprint":false},{"pmid":"25051437","id":"PMC_25051437","title":"Cell-mass structures expressing the aromatase gene Cyp19a1 lead to ovarian cavities in Xenopus laevis.","date":"2014","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25051437","citation_count":14,"is_preprint":false},{"pmid":"2993794","id":"PMC_2993794","title":"Cloning of the ARO cluster gene of Neurospora crassa and its expression in Escherichia coli.","date":"1985","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/2993794","citation_count":14,"is_preprint":false},{"pmid":"11370781","id":"PMC_11370781","title":"3D H(aro)-NOESY-CH3NH and C(aro)-NOESY-CH3NH experiments for double labeled proteins.","date":"2001","source":"Journal of biomolecular NMR","url":"https://pubmed.ncbi.nlm.nih.gov/11370781","citation_count":13,"is_preprint":false},{"pmid":"27337972","id":"PMC_27337972","title":"Enzymatic and Inhibition Mechanism of Human Aromatase (CYP19A1) Enzyme. A Computational Perspective from QM/MM and Classical Molecular Dynamics Simulations.","date":"2016","source":"Mini reviews in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27337972","citation_count":13,"is_preprint":false},{"pmid":"31325085","id":"PMC_31325085","title":"Bone and body composition response to testosterone therapy vary according to polymorphisms in the CYP19A1 gene.","date":"2019","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/31325085","citation_count":13,"is_preprint":false},{"pmid":"38238831","id":"PMC_38238831","title":"METTL3 drives NSCLC metastasis by enhancing CYP19A1 translation and oestrogen synthesis.","date":"2024","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/38238831","citation_count":12,"is_preprint":false},{"pmid":"29553041","id":"PMC_29553041","title":"Aromatase Deficiency due to a Novel Mutation in CYP19A1 Gene.","date":"2018","source":"Journal of clinical research in pediatric endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/29553041","citation_count":12,"is_preprint":false},{"pmid":"34958889","id":"PMC_34958889","title":"Ovarian Toxicity Induced by Aluminum Chloride: Alteration of Cyp19a1, Pcna, Puma, and Map1lc3b genes Expression.","date":"2021","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/34958889","citation_count":11,"is_preprint":false},{"pmid":"31996328","id":"PMC_31996328","title":"miR-326 down-regulate CYP19A1 expression and estradiol-17b production in buffalo granulosa cells through CREB and C/EBP-β.","date":"2020","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31996328","citation_count":11,"is_preprint":false},{"pmid":"29474975","id":"PMC_29474975","title":"Profile of CYP19A1 mRNA expression and aromatase activity during syncytialization of primary human villous trophoblast cells at term.","date":"2018","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/29474975","citation_count":11,"is_preprint":false},{"pmid":"35953905","id":"PMC_35953905","title":"CYP19A1 May Influence Lambing Traits in Goats by Regulating the Biological Function of Granulosa Cells.","date":"2022","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/35953905","citation_count":11,"is_preprint":false},{"pmid":"20662593","id":"PMC_20662593","title":"Intrauterine growth restriction alters hippocampal expression and chromatin structure of Cyp19a1 variants.","date":"2010","source":"Systems biology in reproductive medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20662593","citation_count":11,"is_preprint":false},{"pmid":"32657440","id":"PMC_32657440","title":"Altered expression of CYP17A1 and CYP19A1 in undescended testes of dogs with unilateral cryptorchidism.","date":"2020","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32657440","citation_count":10,"is_preprint":false},{"pmid":"36441497","id":"PMC_36441497","title":"Association of CYP19A1 Gene, Plasma Zinc, and Urinary Zinc with the Risk of Type 2 Diabetes Mellitus in a Chinese Population.","date":"2022","source":"Biological trace element research","url":"https://pubmed.ncbi.nlm.nih.gov/36441497","citation_count":10,"is_preprint":false},{"pmid":"26071589","id":"PMC_26071589","title":"Estrogen receptor alpha (Esr1) regulates aromatase (Cyp19a1) expression in the mouse brain.","date":"2015","source":"Neuro endocrinology letters","url":"https://pubmed.ncbi.nlm.nih.gov/26071589","citation_count":10,"is_preprint":false},{"pmid":"31895872","id":"PMC_31895872","title":"Genetic Variations of CYP19A1 Gene and Stroke Susceptibility: A Case-Control Study in the Chinese Han Population.","date":"2020","source":"Journal of cardiovascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31895872","citation_count":10,"is_preprint":false},{"pmid":"23669293","id":"PMC_23669293","title":"CYP19A1 gene polymorphisms and risk of lung cancer.","date":"2013","source":"The Journal of international medical research","url":"https://pubmed.ncbi.nlm.nih.gov/23669293","citation_count":10,"is_preprint":false},{"pmid":"25522654","id":"PMC_25522654","title":"Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women.","date":"2014","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/25522654","citation_count":10,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":55767,"output_tokens":6776,"usd":0.13447,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15708,"output_tokens":3796,"usd":0.08672,"stage2_stop_reason":"end_turn"},"total_usd":0.22119,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1985,\n      \"finding\": \"Human aromatase (CYP19A1/P-450AROM) was identified as a 55-kDa protein in placental microsomes. Purified protein reconstituted with NADPH-cytochrome P450 reductase and phospholipid displayed aromatase catalytic activity, establishing it as the enzymatically active subunit. Polyclonal IgG against the 55-kDa protein inhibited aromatase activity by 80% with no effect on 17α-hydroxylase or 21-hydroxylase, demonstrating enzymatic specificity.\",\n      \"method\": \"Immunoaffinity chromatography, enzyme reconstitution with purified NADPH-cytochrome P450 reductase and phospholipid, immunoblot, antibody inhibition assay\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution of catalytic activity with purified components plus antibody inhibition with specificity controls; foundational biochemical characterization\",\n      \"pmids\": [\"4083898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"Expression of a chicken CYP19A1 cDNA in COS-1 cells produced high levels of aromatase activity, demonstrating that the single protein catalyzes all three successive oxidation reactions required to convert androgen (androstenedione) to estrogen. The enzyme was correctly targeted to microsomal fractions in transfected cells, with Km similar to native chicken ovarian enzyme.\",\n      \"method\": \"Heterologous cDNA expression in COS-1 cells, microsomal aromatase activity assay, subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct functional expression of cloned cDNA with enzymatic validation and correct subcellular targeting confirmed\",\n      \"pmids\": [\"3182796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"The CYP19A1 gene uses tissue-specific promoters: placenta uses upstream untranslated exons I.1 and I.2 with their associated promoters, whereas adipose tissue uses a distinct promoter approximately 110 bp upstream of exon II with a transcription start site 26 bp downstream of a TATAAA element. These alternative promoters drive tissue-specific aromatase expression.\",\n      \"method\": \"RT-PCR, primer extension analysis, S1 nuclease protection assay, Northern blotting\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (primer extension, S1 nuclease protection, Northern blot) in a single rigorous study establishing tissue-specific promoter usage\",\n      \"pmids\": [\"2040633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"A point mutation at the splice consensus sequence between exon 6 and intron 6 (GT→GC) caused aberrant splicing, inserting 87 bp of intronic sequence encoding 29 extra amino acids in-frame into aromatase mRNA. The resulting abnormal protein had trace aromatase activity when expressed in COS-7 cells, establishing that this splicing mutation is the molecular basis of aromatase deficiency in this patient.\",\n      \"method\": \"cDNA library sequencing, Northern blot, Western blot, transient expression in COS-7 cells, enzyme activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — functional expression of mutant cDNA with activity measurement, molecular characterization of splicing defect with multiple methods\",\n      \"pmids\": [\"1371509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The acyl-carbon bond cleavage mechanism of CYP19A1 involves the iron peroxy anion intermediate (FeIII-O-O-) being trapped by the substrate's C19 aldehyde carbonyl to form a tetrahedral intermediate, which then fragments to cleave the acyl-carbon bond and release the aromatized estrogen product. This distinguishes the CYP19A1 mechanism from classical P450 monooxygenation that proceeds via Compound I.\",\n      \"method\": \"Mechanistic biochemistry review synthesizing isotopic labeling, substrate analog, and structural studies (Tier 1 compilation)\",\n      \"journal\": \"Advances in experimental medicine and biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — mechanistic chemistry well-established by community but this paper is a review; abstract describes the mechanism without citing primary experiments performed in this paper specifically\",\n      \"pmids\": [\"26002733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SIRT1 positively regulates CYP19A1 transcription in breast cancer cells. SIRT1 occupies the CYP19A1 promoter regions PI.3/PII and PI.4. Pharmacologic inhibition of SIRT1 or siRNA knockdown reduced aromatase mRNA and protein. SIRT1 inhibition led to increased acetylation of estrogen-related receptor alpha (ERRα), a transcription factor that activates CYP19A1 transcription in epithelial cells.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), siRNA knockdown, small-molecule SIRT1 inhibitors, qRT-PCR, Western blot\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrates SIRT1 promoter occupancy, supported by siRNA and pharmacologic inhibition with mRNA and protein readouts; single lab, two orthogonal approaches\",\n      \"pmids\": [\"23340254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In chicken ovary theca cells, the transcription factor SF-1 (NR5A1) directly activates CYP19A1 transcription by binding to a nuclear receptor half-site (5'-TCAAGGTCA-3') located −280 to −271 bp in the CYP19A1 promoter. Overexpression of SF-1 in DF-1 cells upregulated aromatase expression. In contrast, FOXL2 did not activate the CYP19A1 promoter in either 293T or DF-1 cells.\",\n      \"method\": \"Luciferase reporter assay, overexpression in cell lines, RT-PCR\",\n      \"journal\": \"General and comparative endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase assay with promoter binding site identified plus overexpression phenotype, single lab\",\n      \"pmids\": [\"28347743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Mutations in the FMN-binding domain of P450 oxidoreductase (POR) at positions A115V and T142A nearly abolished CYP19A1 aromatase activity in a reconstituted in vitro system, and reduced flavin content. POR mutation P284L in the hinge region also severely reduced CYP19A1 activity. Conversely, POR mutation Q153R markedly increased CYP19A1 activity without changing flavin content, suggesting improved POR-CYP19A1 protein-protein interaction.\",\n      \"method\": \"Bacterial expression and purification of recombinant proteins, liposome reconstitution, enzyme kinetic assays, cytochrome c reduction assay, flavin content measurement\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified mutant and wild-type proteins plus multiple functional assays in a single rigorous study\",\n      \"pmids\": [\"28970799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DVL1 and DVL3 (Dishevelled proteins, key Wnt signaling mediators) localize to the nucleus and occupy at least two CYP19A1 promoters (pII and I.4) that drive overexpression in breast tumors, as well as the distal placental promoter I.1. Loss of DVL-1 or DVL-3 function led to differential changes in aromatase transcripts and in estradiol production in breast cancer cell lines.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), loss-of-function experiments, qRT-PCR, estradiol measurement\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP showing DVL promoter occupancy plus loss-of-function with transcriptional and hormonal readouts; single lab\",\n      \"pmids\": [\"30479694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Human placental aromatase CYP19A1 is phosphorylated at multiple sites. Phosphorylation of Y361 at the reductase-coupling interface significantly elevates aromatase catalytic activity. Additional phosphorylation sites include the active-site residue S478 and several membrane-interface residues. Two histidine residues were also found to be phosphorylated. Oxidation of two proline residues near the active site was detected and may regulate activity.\",\n      \"method\": \"Mass spectrometry (phosphoproteomics), biochemical assay, structural data analysis, cellular experiments\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mass spectrometric identification of phosphosites combined with biochemical activity assay and structural data, multiple orthogonal methods in one study\",\n      \"pmids\": [\"31652308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CYP19A1 protein was detected on the plasma membrane of MCF-7 breast cancer cells and of normal MCF-10A breast cells by immunological methods, indicating plasma membrane localization in addition to its canonical endoplasmic reticulum localization. Anti-CYP19A1 autoantibodies were detectable in both breast cancer patients and controls, with no significant group differences.\",\n      \"method\": \"Flow cytometry / immunological detection of cell-surface CYP19A1, indirect ELISA for autoantibodies\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single immunological detection method for plasma membrane localization, single lab, no functional consequence linked to the localization\",\n      \"pmids\": [\"31082724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FSH and TGFβ1 upregulate Cyp19a1 expression in ovarian granulosa cells via calcineurin-mediated dephosphorylation-activation of CRTC2, which binds to the Cyp19a1 PII promoter. LRH1 (NR5A2) and SF1 (NR5A1) protein levels were increased by FSH+TGFβ1, and their binding to the Cyp19a1 PII promoter was demonstrated. Calcineurin auto-inhibitory peptide abolished FSH+TGFβ1-upregulated (but not FSH-alone) aromatase activity, establishing calcineurin as pathway-specific regulator.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), calcineurin inhibitory peptide, Western blot, aromatase activity assay, qRT-PCR\",\n      \"journal\": \"Journal of molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for transcription factor binding plus pathway epistasis via calcineurin inhibition with activity readout; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"25057110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NR1D1 (REV-ERBα), a circadian clock transcriptional repressor, binds to the RORE element on the CYP19A1 promoter in porcine granulosa cells, thereby inhibiting CYP19A1 transcription and reducing estradiol production. NR1D1 activation enhanced this repression, while NR1D1 knockdown relieved it.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), luciferase reporter assay, NR1D1 activation/interference experiments, ELISA for estradiol\",\n      \"journal\": \"Theriogenology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct NR1D1-promoter binding with luciferase reporter and hormonal readouts; single lab\",\n      \"pmids\": [\"34933195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LPS activates TLR4 signaling in buffalo granulosa cells, leading to increased CEBPB expression and nuclear translocation. CEBPB binds to the CYP19A1 proximal promoter (PII) and represses CYP19A1 transcription, resulting in decreased estradiol production. TLR4 inhibitor (OxPAPC) attenuated these effects.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), TLR4 inhibitor treatment, Western blot, qRT-PCR, ELISA\",\n      \"journal\": \"Toxicology in vitro\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrates CEBPB binding at CYP19A1 PII promoter with pathway inhibitor epistasis; single lab\",\n      \"pmids\": [\"28412504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The RNA-binding protein CELF1 directly binds Cyp19a1 mRNA and represses its translation. In Celf1 knockout mice, Cyp19a1 is posttranscriptionally upregulated, leading to excessive aromatase activity, reduced testosterone, and impaired spermiogenesis. Administration of testosterone or the aromatase inhibitor letrozole partially rescued the spermiogenesis defects, placing CELF1-mediated translational repression of CYP19A1 in the pathway controlling intratesticular testosterone levels required for spermiogenesis.\",\n      \"method\": \"In vivo/in vitro RNA binding assay, reporter assay for translational repression, Celf1 knockout mouse model, hormone measurements, rescue experiments with testosterone and letrozole\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct RNA binding demonstrated, translational repression confirmed in reporter assay, in vivo knockout with defined phenotype, pharmacological rescue; multiple orthogonal methods\",\n      \"pmids\": [\"26169831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"METTL3, an m6A methyltransferase, enhances CYP19A1 mRNA translation efficiency in an m6A-dependent manner in NSCLC cells. METTL3 interacts with translation initiation factors and binds to CYP19A1 mRNA, promoting aromatase protein synthesis and estrogen production to drive NSCLC metastasis. Pharmacological inhibition of METTL3 or eIF4E abolished CYP19A1 protein synthesis.\",\n      \"method\": \"Translatomics, m6A-seq, RNA immunoprecipitation, co-immunoprecipitation, Western blot, METTL3 knockdown/knockout, eIF4E inhibitor, in vitro and in vivo invasion assays\",\n      \"journal\": \"Cell & bioscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (translatomics, RIP, Co-IP, pharmacological inhibition) demonstrating METTL3-eIF4E-CYP19A1 translation axis; single lab\",\n      \"pmids\": [\"38238831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CTBP1 and EP300 bind to the CYP19A1 promoter in PCa cells and downregulate CYP19A1 expression. Estradiol, acting through estrogen receptor beta, releases CTBP1 from the CYP19A1 promoter, thereby de-repressing CYP19A1 transcription and increasing estradiol production. In CTBP1-depleted PCa xenografts in NSG mice, CYP19A1 expression and intratumoral estradiol were increased.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), CTBP1 depletion, xenograft mouse model, hormone measurement, Western blot\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating CTBP1/EP300 promoter occupancy with in vivo depletion validation; single lab, multiple methods\",\n      \"pmids\": [\"30152543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RORα directly occupies the promoter of CYP19A1 in THP-1 monocytes and HUVEC cells, as shown by ChIP. Modulating RORα activity with specific ligands (CPG 52608 and SR1001) altered CYP19A1 expression, establishing CYP19A1 as a direct RORα target gene. Simvastatin downregulated CYP19A1 expression, and this was partially prevented by RORα ligands.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), RORα ligand treatment, qRT-PCR\",\n      \"journal\": \"Cell biology international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirms RORα occupancy at CYP19A1 promoter, supported by pharmacological modulation of RORα activity; single lab\",\n      \"pmids\": [\"27925372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In chicken embryos, lentiviral-mediated knockdown of CYP19A1 caused male sex reversal, while overexpression drove female sex differentiation, establishing CYP19A1 as both necessary and sufficient to initiate female gonadal sex differentiation. CYP19A1 showed sexually dimorphic expression in female gonads from embryonic day 5.5, localized to ovarian medullas.\",\n      \"method\": \"Lentiviral in ovo knockdown and overexpression, aromatase inhibitor treatment, immunohistochemistry, gonadal sex phenotype analysis\",\n      \"journal\": \"Bioscience reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss- and gain-of-function in vivo experiments with defined gonadal phenotype, combined with pharmacological inhibition; multiple orthogonal approaches\",\n      \"pmids\": [\"32990306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Transcription factors ESR1, ESR2, and NR5A2 form a functional regulatory network controlling CYP19A1 expression in chicken theca cells. ESR1 and NR5A2 activated the CYP19A1 promoter in luciferase assays; overexpression of ESR1, ESR2, or NR5A2 upregulated CYP19A1 protein and these factors mutually restricted each other. In contrast, FOXL2 did not regulate CYP19A1 expression at embryonic stages or after sexual maturity in chicken.\",\n      \"method\": \"Luciferase reporter assay, overexpression in DF-1 and theca cells, Western blot, immunofluorescence\",\n      \"journal\": \"General and comparative endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase assay plus overexpression in physiologically relevant theca cell culture; single lab, two orthogonal methods\",\n      \"pmids\": [\"34710471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CYP19A1 expression is increased in the lungs of SARS-CoV-2-infected male golden hamsters and in human autopsy lungs of males. A CYP19A1-activity-increasing mutation was associated with severe COVID-19 in men. Increased pulmonary CYP19A1 was associated with dysregulated plasma sex hormones and impaired long-term lung function specifically in males. Treatment with the CYP19A1 inhibitor letrozole improved lung function and restored sex hormone balance in infected male hamsters.\",\n      \"method\": \"Exome sequencing with machine-learning analysis, human autopsy immunohistochemistry, hamster infection model with letrozole treatment, lung function measurement, hormone assays\",\n      \"journal\": \"Cell reports. Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo pharmacological inhibition with functional readout in animal model plus human genetic and autopsy data; multi-method, single study\",\n      \"pmids\": [\"37572667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"miR-326 inhibits CYP19A1 transcription in buffalo granulosa cells by upregulating CREB, which activates C/EBP-β; increased C/EBP-β then binds the CYP19A1 PII promoter (shown by ChIP) and reduces RNA polymerase II binding, thereby decreasing CYP19A1 mRNA and estradiol-17β production.\",\n      \"method\": \"miRNA mimic transfection, ChIP for C/EBP-β and RNA Pol II at CYP19A1 PII promoter, qRT-PCR, ELISA\",\n      \"journal\": \"The Journal of steroid biochemistry and molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating transcription factor binding changes at CYP19A1 promoter with miRNA functional experiments; single lab\",\n      \"pmids\": [\"31996328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"LPS-mediated inhibition of CYP19A1 expression and estradiol production in granulosa cells involves HDAC-dependent histone deacetylation at H3K9 of the CYP19A1 PII proximal promoter and NF-κB nuclear translocation. The HDAC inhibitor TSA prevented H3 deacetylation at PII (confirmed by ChIP) and restored CYP19A1 expression and estradiol production, placing HDAC activity as a downstream effector of LPS/NF-κB signaling in CYP19A1 repression.\",\n      \"method\": \"HDAC inhibitor (TSA), ChIP for H3(K9/14) acetylation at CYP19A1 PII, NF-κB nuclear translocation assay, qRT-PCR, ELISA\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating histone modification at CYP19A1 promoter with pharmacological reversal; single lab, multiple methods\",\n      \"pmids\": [\"26213324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LRH-1 (liver receptor homolog-1) protein directly binds the CYP19A1 promoter and increases its transcriptional activity in porcine granulosa cells (shown by luciferase and ChIP assays). miR-1275 targets the 3'UTR of LRH-1 mRNA (not CYP19A1 directly), suppressing LRH-1 expression and thereby reducing CYP19A1 transcription, estradiol synthesis, and promoting granulosa cell apoptosis.\",\n      \"method\": \"Luciferase reporter assay, ChIP, miRNA overexpression/knockdown, in vitro LRH-1 overexpression/knockdown, flow cytometry\",\n      \"journal\": \"Biochimica et biophysica acta. Gene regulatory mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and luciferase assay confirm LRH-1 binding to CYP19A1 promoter; miRNA-target validated by luciferase; single lab\",\n      \"pmids\": [\"29378329\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CYP19A1 encodes aromatase, a cytochrome P450 enzyme resident in the endoplasmic reticulum (and detectable on the plasma membrane) that catalyzes three successive oxidations of androgen substrates via an iron peroxy-anion-mediated acyl-carbon cleavage mechanism to produce estrogens; its activity is regulated post-translationally by POR-dependent electron transfer (modulated by POR mutations) and by phosphorylation at multiple sites including Y361 (activating) and S478, and transcriptionally through a network of tissue-specific promoters controlled by SF-1/NR5A1, LRH-1/NR5A2, ESR1, ESR2, RORα, NR1D1, CTBP1/EP300, SIRT1, DVL proteins, and epigenetic marks (histone acetylation via HDACs, CRTC2/calcineurin), while at the post-transcriptional level CELF1 represses Cyp19a1 mRNA translation and METTL3/eIF4E promotes it via m6A modification.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CYP19A1 encodes aromatase, a microsomal cytochrome P450 that is the single enzyme catalyzing the three successive oxidations converting androgens to estrogens, the committed step of estrogen biosynthesis [#0, #1]. Purified placental aromatase reconstituted with NADPH-cytochrome P450 reductase and phospholipid is catalytically active and immunologically distinct from other steroid hydroxylases [#0], and heterologous expression of a single cDNA confers full androstenedione-to-estrogen conversion with correct microsomal targeting [#1]. Catalysis proceeds through an unusual iron peroxy-anion intermediate that is trapped by the substrate C19 aldehyde to cleave the acyl-carbon bond and aromatize the steroid A-ring, distinguishing it from canonical Compound I P450 chemistry [#4]. Enzyme activity depends on productive electron transfer from POR, as POR FMN-domain and hinge mutations abolish or enhance aromatase activity in reconstituted systems [#7], and is further tuned post-translationally by phosphorylation, including activating phosphorylation of Y361 at the reductase-coupling interface [#9]. Transcription is governed by a network of tissue-specific promoters [#2] integrating nuclear-receptor activators (SF-1/NR5A1, LRH-1/NR5A2, ESR1/ESR2, RORα) and repressors (NR1D1, CEBPB, CTBP1/EP300), along with epigenetic and signaling inputs such as SIRT1, CRTC2/calcineurin, HDAC-dependent H3K9 acetylation, and DVL proteins [#5, #6, #11, #12, #16, #17, #19, #22, #8]; at the post-transcriptional level CELF1 represses Cyp19a1 mRNA translation while METTL3/eIF4E promotes it via m6A [#14, #15]. Functionally, aromatase-derived estrogen drives gonadal sex differentiation, being necessary and sufficient for female development in the avian gonad [#18], controls intratesticular testosterone required for spermiogenesis [#14], and contributes to pathological estrogen production in cancers and to sex-biased COVID-19 lung pathology [#16, #20]. Loss-of-function splicing mutations that cripple aromatase activity underlie human aromatase deficiency [#3].\",\n  \"teleology\": [\n    {\n      \"year\": 1985,\n      \"claim\": \"Established that aromatase is a discrete P450 protein and the catalytically active subunit, answering whether estrogen synthesis required a dedicated enzyme.\",\n      \"evidence\": \"Immunoaffinity purification of 55-kDa placental protein, reconstitution with NADPH-P450 reductase and phospholipid, antibody inhibition with specificity controls\",\n      \"pmids\": [\"4083898\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve whether one protein performs all three oxidations\", \"No structural or mechanistic detail of catalysis\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Demonstrated that a single CYP19A1 gene product catalyzes all three oxidation steps from androgen to estrogen, settling the one-enzyme question.\",\n      \"evidence\": \"Heterologous expression of chicken CYP19A1 cDNA in COS-1 cells with microsomal activity assay and subcellular fractionation\",\n      \"pmids\": [\"3182796\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chemical mechanism of acyl-carbon cleavage not defined\", \"Regulation in vivo not addressed\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Revealed that tissue-specific aromatase expression is driven by alternative promoters, explaining how the same enzyme is differentially produced across tissues.\",\n      \"evidence\": \"RT-PCR, primer extension, S1 nuclease protection and Northern blot of placental vs adipose transcripts\",\n      \"pmids\": [\"2040633\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-acting factors driving each promoter not identified here\", \"Did not address regulation in disease\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Linked a CYP19A1 splice mutation directly to human aromatase deficiency, establishing the gene as the disease locus.\",\n      \"evidence\": \"Patient cDNA sequencing, Northern/Western blot, expression of mutant cDNA in COS-7 with activity assay\",\n      \"pmids\": [\"1371509\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single patient mutation\", \"Genotype-phenotype spectrum not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined the unusual acyl-carbon cleavage chemistry of aromatization, distinguishing CYP19A1 from canonical monooxygenase P450s.\",\n      \"evidence\": \"Mechanistic biochemistry review synthesizing isotopic, substrate-analog and structural studies\",\n      \"pmids\": [\"26002733\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Review rather than new primary experiment\", \"Intermediate species not directly observed in this work\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified CELF1-mediated translational repression of Cyp19a1 as a post-transcriptional control point governing intratesticular testosterone and spermiogenesis.\",\n      \"evidence\": \"RNA-binding and reporter assays, Celf1 knockout mice, hormone measurement, testosterone/letrozole rescue\",\n      \"pmids\": [\"26169831\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"CELF1 binding element on Cyp19a1 mRNA not mapped\", \"Translational machinery involved not detailed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed POR electron-transfer function controls aromatase output, with FMN-domain and hinge mutations bidirectionally modulating activity.\",\n      \"evidence\": \"Bacterial expression, liposome reconstitution of WT/mutant POR with CYP19A1, kinetics, cytochrome c reduction, flavin content\",\n      \"pmids\": [\"28970799\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of altered POR-CYP19A1 interaction not solved\", \"Tissue-level consequences not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Mapped multiple nuclear-receptor and signaling regulators (SF-1, RORα, LRH-1, LPS/CEBPB) to specific CYP19A1 promoter elements, building the transcriptional network.\",\n      \"evidence\": \"ChIP, luciferase reporters, overexpression/knockdown and ligand/pathway-inhibitor experiments in granulosa, theca, monocyte and endothelial systems\",\n      \"pmids\": [\"28347743\", \"27925372\", \"29378329\", \"28412504\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Largely single-lab, non-human cell systems\", \"Combinatorial promoter logic across factors not integrated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established phosphorylation, including activating Y361 at the reductase interface, as a post-translational regulator of aromatase activity.\",\n      \"evidence\": \"Phosphoproteomic mass spectrometry of placental aromatase with biochemical activity assay and structural analysis\",\n      \"pmids\": [\"31652308\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinases responsible not identified\", \"Physiological stimuli driving phosphorylation unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Reported plasma-membrane localization of CYP19A1 in addition to the ER, raising the possibility of non-canonical surface display.\",\n      \"evidence\": \"Flow cytometry/immunological detection on MCF-7 and MCF-10A cells, autoantibody ELISA\",\n      \"pmids\": [\"31082724\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single immunological method without orthogonal confirmation\", \"No functional consequence assigned to surface localization\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated that CYP19A1 is necessary and sufficient to initiate female gonadal sex differentiation in vivo.\",\n      \"evidence\": \"Lentiviral knockdown and overexpression in chicken embryos, aromatase inhibitor, immunohistochemistry, gonadal phenotyping\",\n      \"pmids\": [\"32990306\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian relevance not addressed\", \"Upstream initiating cue for dimorphic expression unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Expanded CYP19A1's pathophysiology beyond reproduction, linking elevated pulmonary aromatase to sex-biased COVID-19 severity.\",\n      \"evidence\": \"Hamster infection model with letrozole treatment, human autopsy IHC, exome sequencing with machine learning, hormone and lung-function assays\",\n      \"pmids\": [\"37572667\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of pulmonary CYP19A1 induction unclear\", \"Causality of the activating mutation not functionally proven\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the diverse transcriptional, translational (m6A), and post-translational inputs are integrated into a coherent, tissue- and context-specific control of aromatase output remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking promoter choice, phosphorylation, and POR coupling\", \"Human structural mechanism of acyl-carbon cleavage not directly visualized in the corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 1, 4, 7]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 6, 16, 17, 19]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [18, 14]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"POR\",\n      \"NR5A1\",\n      \"NR5A2\",\n      \"ESR1\",\n      \"ESR2\",\n      \"RORA\",\n      \"CELF1\",\n      \"METTL3\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}